je.st
news
BioCryst Pharmaceuticals Price Target Lowered to $10.00 at Jefferies Group
2015-10-18 09:44:56| Biotech - Topix.net
The firm presently has a "hold" rating on the biotechnology company's stock. Jefferies Group's price objective would indicate a potential upside of 13.12% from the stock's previous close.
Tags: price
group
target
lowered
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||